Elizabeth K Kauffmann

Title: The Innovations of Elizabeth K. Kauffmann

Introduction

Elizabeth K. Kauffmann is a notable inventor based in Averill Park, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of recombinant viruses for therapeutic applications. His work has implications for preventive and diagnostic uses in medicine.

Latest Patents

Kauffmann holds a patent for "Recombinant poxvirus cytomegalovirus, compositions, and uses." This patent describes attenuated recombinant viruses that contain DNA encoding an HCMV antigen. The invention includes methods and compositions that utilize these viruses, expression products derived from them, and antibodies generated from the viruses or their expression products. The recombinant viruses can be NYVAC or ALVAC types. The DNA of these recombinant viruses can also be employed as probes or for generating PCR primers, showcasing their versatility in various applications.

Career Highlights

Kauffmann is associated with Virogenetics Corporation, where he has been instrumental in advancing research in recombinant virus technology. His innovative work has positioned him as a key figure in the biotechnology sector, contributing to the development of new therapeutic strategies.

Collaborations

Some of his notable coworkers include Enzo Paoletti and Steven E. Pincus. Their collaborative efforts have further enhanced the research and development initiatives at Virogenetics Corporation.

Conclusion

Elizabeth K. Kauffmann's contributions to biotechnology through his patent and work at Virogenetics Corporation highlight the importance of innovation in medical research. His advancements in recombinant virus technology pave the way for new therapeutic and diagnostic solutions.